Pfizer Sues Impax Over Detrol ANDA

Law360, New York (June 2, 2011, 7:16 PM EDT) -- Pfizer Inc. filed a patent infringement suit Tuesday in New Jersey federal court against Impax Laboratories Inc. over the generics maker's abbreviated new drug application for a generic version of bladder control drug Detrol.

Pfizer, Pharmacia & Upjohn Co. LLC and Pfizer Health AB argue a final judgment in another dispute between the companies over the same patent, U.S. Patent Number 5,382,600, prevents Impax from bringing generic Detrol to market.

In that suit, filed in 2008 and currently pending in the same court, Pfizer sued Impax...
To view the full article, register now.